Erythropoietin promotes the growth of tumors lacking its receptor and decreases survival of tumor-bearing mice by enhancing angiogenesis. - Wikidata - wikimedia - TriplyDB

Erythropoietin promotes the growth of tumors lacking its receptor and decreases survival of tumor-bearing mice by enhancing angiogenesis.

Erythropoietin promotes the growth of tumors lacking its receptor and decreases survival of tumor-bearing mice by enhancing angiogenesis.

http://www.wikidata.org/entity/Q36840259

about

Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivation Depletion of serotonin and selective inhibition of 2B receptor suppressed tumor angiogenesis by inhibiting endothelial nitric oxide synthase and extracellular signal-regulated kinase 1/2 phosphorylation Dinosaurs and ancient civilizations: reflections on the treatment of cancer The use of recombinant erythropoietin for the treatment of chemotherapy-induced anemia in patients with ovarian cancer does not affect progression-free or overall survival.Neoplasia: the second decade.Limitations of a murine transgenic breast cancer model for studies of erythropoietin-induced tumor progression.The effect of erythropoietin on normal and neoplastic cells.Erythropoietin and cancer: the unintended consequences of anemia correction Epo receptors are not detectable in primary human tumor tissue samples Epoetin beta for the treatment of chemotherapy-induced anemia: an update.Erythropoietin improves the accumulation and therapeutic effects of carboplatin by enhancing tumor vascularization and perfusion Erythropoietin Stimulates Tumor Growth via EphB4.Erythropoietin promotes the growth of pituitary adenomas by enhancing angiogenesis.Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients.Far-western blotting as a solution to the non-specificity of the anti-erythropoietin receptor antibody Recombinant human epoetin beta in the treatment of chemotherapy-related anemia.Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response.Erythropoietin is a JAK2 and ERK1/2 effector that can promote renal tumor cell proliferation under hypoxic conditions.The War on Cancer rages on.Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal.Predictive mathematical models of cancer signalling pathways.In-vivo detection of the erythropoietin receptor in tumours using positron emission tomography.Loss of prolyl hydroxylase-2 in myeloid cells and T-lymphocytes impairs tumor development.Erythropoietin and Its Angiogenic Activity.Erythropoietin receptor contributes to melanoma cell survival in vivo.Erythropoietin increases macrophage-mediated T cell suppression.An unusual case of malignant thymoma associated graft-versus-host disease Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma.Long-term moderate dose exogenous erythropoietin treatment protects from intermittent hypoxia-induced spatial learning deficits and hippocampal oxidative stress in young rats.Epo is involved in angiogenesis in human glioma.Royal jelly prevents the progression of sarcopenia in aged mice in vivo and in vitro.Role of Erythropoietin and Other Growth Factors inEx VivoErythropoiesis

P2860

Q24306910-79F6B3B5-A4DA-4CA4-B7BF-585383632408 Q24309173-1E35F06A-3B0D-4DE1-B5DB-0058BEE39306 Q24628746-AE0C247F-0621-44C1-A48A-0DBD39946566 Q30453014-3FF11AA3-F75D-4A0A-AE90-91C933982C27 Q30484000-68734108-419A-4752-8C68-FFE986FDFFD4 Q33920934-024A7288-93C9-4E2F-A6F0-FE8978680156 Q34291437-60ED463F-94F7-4C52-847B-C577C8DD4E0A Q34488415-0EDAE986-8701-4FD0-89BF-AED14116339A Q34826770-EA59EDD9-CA47-4F97-B8C1-23666F31705F Q35168681-3F145EDE-BD9A-4D2C-BF7A-FA1C3B129DF8 Q35633372-E04FC6EE-8646-46EA-ADC2-4F44415FB91F Q36275814-970C2FD6-4A71-406B-BD67-C924B194F8CB Q36645651-A9D8DD4A-C0C3-4169-9502-4FA8EC47E13E Q37046655-FD53D699-1407-4FCC-9B66-1BC719FA5ED8 Q37107771-94EC46C2-719D-4FF5-886F-B8D5FF5E8DD6 Q37230276-BC4EC2B6-F021-40A5-8E7B-3C945F0FC3E2 Q37328549-C9C290D0-54CE-44E4-A6A3-DB366E2A49C1 Q37351764-318D2D9C-2D8D-4AE0-9332-2A8602684645 Q37478602-3B0AD588-A674-44C5-9A6D-C997FFD9C7C9 Q37524229-B6FBAD05-1118-4965-98D6-D4DF64A0B339 Q37964775-F5FF0FDF-89AF-4829-81AA-F14D89B0D1FB Q38958980-5003CDC5-E27D-4DC8-99CB-58F10A4A8B6B Q39372905-CA579842-E145-40FB-B9FF-52C71858F300 Q39432541-DA12D8C6-06B6-4AE5-8B71-EDC930EAD9A8 Q39486076-C4FB610F-9784-448E-850F-4639858901F5 Q41807007-61FE4696-6511-4DF0-91AF-783ECDBE9375 Q42266863-3EA6D5C4-8DCC-47AD-A1DA-0496CEE139B5 Q44034165-53DCD240-70D3-4242-8545-41D599980F06 Q45976217-992D45A9-7CC7-4D21-94B7-BB3478B9BFC1 Q48135959-9B76C239-DD3C-4D40-B385-5B8C1F68E6F5 Q51009131-D4CFA58A-CD4F-43E0-BA19-7A45F3DAC450 Q59051222-FA90F340-723B-4ECA-91BE-23041413EE31

P2860

Erythropoietin promotes the growth of tumors lacking its receptor and decreases survival of tumor-bearing mice by enhancing angiogenesis.

http://www.wikidata.org/entity/Q36840259

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Erythropoietin promotes the gr ...... ice by enhancing angiogenesis.

@en

type

label

Erythropoietin promotes the gr ...... ice by enhancing angiogenesis.

@en

prefLabel

Erythropoietin promotes the gr ...... ice by enhancing angiogenesis.

@en

P1433

Q36840259-E8B0B5C8-0932-4B36-9276-011C61C0B656

P1476

Q36840259-3BEB6C37-6FD4-4339-94C3-AF33FB134681

P2093

Q36840259-4328FFD2-F101-479A-AB9A-1BA565D06E00

Q36840259-6A93DBC7-7348-412E-9927-5C9925CDC8B7

Q36840259-6D8D21E9-50F7-43D0-9D79-1E0F42F94E1D

Q36840259-9A70F660-4920-47E1-AF5A-F35C05D5B697

Q36840259-D2282990-2C07-4E4E-B3FB-61D6E371A224

Q36840259-E02F4D4D-0157-4CBC-AC9D-93784837967D

P2860

Q36840259-07CF8B11-ADB5-49C1-9C26-55670898DE4B

Q36840259-0D962EED-5295-4286-9D0F-BCAF3BBD525D

Q36840259-17188115-8A15-4094-8722-D905F97880C7

Q36840259-20378884-6DCD-421D-85D6-ED0C6F44C2D3

Q36840259-297DC0DE-930E-4C04-828C-56BA4AACF36B

Q36840259-2B06FF90-DABF-4318-BB68-E8A85687CEFF

Q36840259-35587440-3B78-4AE3-95AD-733F2DDBCF42

Q36840259-381FA030-B4AC-40B4-8366-A88796789A6A

Q36840259-3FB3B71F-1322-4015-8B7A-FF910AC234E1

Q36840259-46F3826A-106E-4074-9AFE-C04B6D842BA0

P304

Q36840259-43312F96-8FC2-46DA-9BDB-A9D19CBA2F6A

P31

Q36840259-BA2438C4-1515-4C54-B1A1-17C0D30DAA3F

P356

Q36840259-CDDE2FAB-FBF1-49E5-A5F3-77DDC9A1A84A

P433

Q36840259-770BAD0B-6C42-4E31-81CE-7C0F2EE3010A

P478

Q36840259-F057243C-B3F5-457C-8701-22BA54771A8D

P577

Q36840259-81440396-0F1D-4910-9038-1E844FE11B05

P5875

Q36840259-D23AB753-C23A-451F-A2AA-045242F6A7FA

P698

Q36840259-3263F63A-8004-4A08-B311-7E55E46DEE62

P921

Q36840259-29E76669-317A-4FDB-BE5E-C7BB8C04D5F1

P932

Q36840259-F66F8277-8B3B-4B5C-94E8-FF1EBC046DEC

P356

P1433

P1476

Erythropoietin promotes the gr ...... ice by enhancing angiogenesis.

@en

P2093

Hiroyuki Arai

http://www.w3.org/2001/XMLSchema#string

Kaijun Niu

http://www.w3.org/2001/XMLSchema#string

Masanori Asada

http://www.w3.org/2001/XMLSchema#string

Satoru Ebihara

http://www.w3.org/2001/XMLSchema#string

Shinsuke Yamanda

http://www.w3.org/2001/XMLSchema#string

Tatsuma Okazaki

http://www.w3.org/2001/XMLSchema#string

P2860

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration

Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF-kappa B activation and protection from cell death

Cyclooxygenase 2- and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polyps

Angiogenesis in cancer, vascular, rheumatoid and other disease

Angiogenesis as a therapeutic target

Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells.

Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development.

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.

Erythropoietin promotes survival of primary human endothelial cells through PI3K-dependent, NF-kappaB-independent upregulation of Bcl-xL.

P304

932-939

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1593/NEO.08140

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2008-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23181626

http://www.w3.org/2001/XMLSchema#string

P698

18714393

http://www.w3.org/2001/XMLSchema#string

P921

P932

2517637

http://www.w3.org/2001/XMLSchema#string